OncoTherapy Science, Inc. (FRA:30O)

OncoTherapy Science Revenue

OncoTherapy Science had revenue of 230.00M JPY in the quarter ending September 30, 2025, with 84.00% growth. This brings the company's revenue in the last twelve months to 956.00M, up 99.58% year-over-year. In the fiscal year ending March 31, 2025, OncoTherapy Science had annual revenue of 750.00M with 22.95% growth.

• Revenue (ttm): 956.00M JPY
• Revenue Growth: +99.58%
• P/S Ratio: 7.16
• Revenue / Employee: 20.34M JPY
• Employees: 47
• Market Cap: 39.40M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	750.00M	140.00M	22.95%
Mar 31, 2024	610.00M	-524.00M	-46.21%
Mar 31, 2023	1.13B	-19.00M	-1.65%
Mar 31, 2022	1.15B	821.00M	247.29%
Mar 31, 2021	332.00M	16.00M	5.06%